Substance P receptor antagonist inhibits murine IgM expression in developing schistosome granulomas by blocking the terminal differentiation of intragranuloma B cells (English)
- New search for: Blum, A.
- New search for: Metwali, A.
- New search for: Elliott, D.
- New search for: Sandor, M.
- New search for: Lynch, R.
- New search for: Weinstock, J. V.
- New search for: Blum, A.
- New search for: Metwali, A.
- New search for: Elliott, D.
- New search for: Sandor, M.
- New search for: Lynch, R.
- New search for: Weinstock, J. V.
In:
JOURNAL OF NEUROIMMUNOLOGY
;
66
, 1/2
;
1-10
;
1996
-
ISSN:
- Article (Journal) / Print
-
Title:Substance P receptor antagonist inhibits murine IgM expression in developing schistosome granulomas by blocking the terminal differentiation of intragranuloma B cells
-
Contributors:Blum, A. ( author ) / Metwali, A. ( author ) / Elliott, D. ( author ) / Sandor, M. ( author ) / Lynch, R. ( author ) / Weinstock, J. V. ( author )
-
Published in:JOURNAL OF NEUROIMMUNOLOGY ; 66, 1/2 ; 1-10
-
Publisher:
- New search for: ELSEVIER SCIENCE DIVISION
-
Publication date:1996-01-01
-
Size:10 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.8
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.8 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 66, Issue 1/2
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
Substance P receptor antagonist inhibits murine IgM expression in developing schistosome granulomas by blocking the terminal differentiation of intragranuloma B cellsBlum, A. / Metwali, A. / Elliott, D. / Sandor, M. / Lynch, R. / Weinstock, J. V. et al. | 1996
- 11
-
Production and role of cytokines in the CNS of mice with acute viral encephalomyelitisMokhtarian, F. / Wesselingh, S. L. / Choi, S. / Maeda, A. / Griffin, D. E. / Sobel, R. A. / Grob, D. et al. | 1996
- 23
-
Muscarinic cholinergic receptor subtypes in the pigeon bursa of Fabricius: a radioligand binding and autoradiographic studyRicci, A. / Bronzetti, E. / Felici, L. / Ciriaco, E. / Vega, J. A. / Germana, G. et al. | 1996
- 29
-
Complement activation on human neuroblastoma cell lines in vitro: route of activation and expression of functional complement regulatory proteinsGasque, P. / Thomas, A. / Fontaine, M. / Morgan, B. P. et al. | 1996
- 41
-
Rat homolog of mouse interleukin-1 receptor accessory protein: cloning, localization and modulation studiesLiu, C. / Chalmers, D. / Maki, R. / De Souza, E. B. et al. | 1996
- 49
-
A pilot study investigating the effects of orally administered pentoxifylline on selected immune variables in patients with multiple sclerosisVan Oosten, B. W. / Rep, M. H. G. / Van Lier, R. A. W. / Scholten, P. E. T. / Von Blomberg, B. M. E. / Pflughaupt, K. W. / Hartung, H. P. / Ader, H. J. / Polman, C. H. et al. | 1996
- 57
-
Multiple sclerosis: prospective analysis of TNF- and 55 kDa TNF receptor in CSF and serum in correlation with clinical and MRI activitySpuler, S. / Yousry, T. / Scheller, A. / Voltz, R. / Holler, E. / Hartmann, M. / Wick, M. / Hohlfeld, R. et al. | 1996
- 65
-
Interleukin-1 receptors type I and type II in the mouse brain: kinetics of mRNA expressions after peripheral administration of bacterial lipopolysaccharideGabellec, M.-M. / Griffais, R. / Fillion, G. / Haour, F. et al. | 1996
- 71
-
Multiple antibodies to nerve glycoconjugates in a patient with neuropathy and monoclonal IgA gammopathyFarrer, R. G. / Dalakas, M. C. / Quarles, R. H. et al. | 1996
- 77
-
Oral tolerance in EAE: reversal of tolerance by T helper cell cytokinesKelly, K. A. / Whitacre, C. C. et al. | 1996
- 85
-
Affinity of anti-GM1 antibodies in Guillain-Barre syndrome patientsDeisenhammer, F. / Keir, G. / Pfausler, B. / Thompson, E. J. et al. | 1996
- 95
-
A novel ganglioside, 9-O-acetyl GD1b, is recognized by serum antibodies in Guillain-Barre syndromeHitoshi, S. / Kusunoki, S. / Kon, K. / Chiba, A. / Waki, H. / Ando, S. / Kanazawa, I. et al. | 1996
- 103
-
Blood-brain barrier breakdown and increased intercellular adhesion molecule (ICAM-1/CD54) expression after Semliki Forest (A7) virus infection facilitates the development of experimental allergic encephalomyelitisEraelinna, J. P. / Soilu-Haenninen, M. / Roeyttae, M. / Hukkanen, V. / Salmi, A. A. / Salonen, R. et al. | 1996
- 115
-
Multiple sclerosis: the proinflammatory cytokines lymphotoxin- and tumour necrosis factor- are upregulated in cerebrospinal fluid mononuclear cellsMatusevicius, D. / Navikas, V. / Soederstroem, M. / Xiao, B.-G. / Haglund, M. / Fredrikson, S. / Link, H. et al. | 1996
- 125
-
Control of lymphocyte adhesion to brain and aortic endothelium: ICAM-1, VCAM-1 and negative chargeDos Santos, W. L. C. / Rahman, J. / Klein, N. / Male, D. K. et al. | 1996
- 135
-
Interleukin-1 differentially affects interleukin-6 and soluble interleukin-6 receptor in the blood and central nervous system of the monkeyReyes, T. M. / Coe, C. L. et al. | 1996
- 143
-
Plasma increase of interleukin-12 and interferon-gamma Pathological significance in autismSingh, V. K. et al. | 1996
- 147
-
Expression pattern of activation and adhesion molecules on peripheral blood CD4^+ T-lymphocytes in relapsing-remitting multiple sclerosis patients: a serial analysisStueber, A. / Martin, R. / Stone, L. A. / Maloni, H. / McFarland, H. F. et al. | 1996